Skip to main content
. 2009 Oct 29;21(6):1196–1202. doi: 10.1093/annonc/mdp460

Figure 2.

Figure 2.

Overall survival according to myeloma-associated antigen-1 expression for patients receiving chemotherapy plus monoclonal antibody on studies S9800 and S9911 (A) and chemotherapy only on study S8809 (B).